JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
GLIBA
3501
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $1.27M | ﹤0.01% |
22,759
+1,459
| +7% | +$73.8K |
2018 Q1
4 quarters
|
|
3502
Invesco DB Commodity Index Tracking Fund
DBC
$1.94B
| $1.26M | ﹤0.01% |
79,600
-13,368
| -14% | -$209K |
2013 Q2
23 quarters
|
|
3503
Marten Transport
MRTN
$1.05B
| $1.26M | ﹤0.01% |
106,388
-22,749
| -18% | -$278K |
2015 Q4
13 quarters
|
|
|
CURO
3504
DELISTED
CURO Group Holdings Corp.
CURO
| $1.26M | ﹤0.01% |
126,016
+120,595
| +2,225% | +$1.32M |
2018 Q1
4 quarters
|
|
|
INWK
3505
DELISTED
InnerWorkings, Inc.
INWK
| $1.26M | ﹤0.01% |
348,861
-178,710
| -34% | -$800K |
2016 Q4
9 quarters
|
|
3506
CALL
BioMarin Pharmaceuticals
BMRN
$10.9B
| $1.25M | ﹤0.01% |
14,100
-16,300
| -54% | -$1.51M |
2017 Q4
5 quarters
|
|
|
ESV
3507
DELISTED
Ensco Rowan plc
ESV
| $1.25M | ﹤0.01% |
79,627
-5,918
| -7% | -$103K |
2013 Q2
23 quarters
|
|
|
NVRO
3508
PUT
DELISTED
NEVRO CORP.
NVRO
| $1.25M | ﹤0.01% |
+20,000
| New | +$940K |
2019 Q1
0 quarters
|
|
3509
PetMed Express
PETS
$28.4M
| $1.25M | ﹤0.01% |
54,805
-35,396
| -39% | -$798K |
2015 Q4
13 quarters
|
|
3510
iShares Core S&P US Growth ETF
IUSG
$35B
| $1.25M | ﹤0.01% |
20,681
-5,565
| -21% | -$319K |
2016 Q1
12 quarters
|
|
3511
PUT
Dave & Buster's
PLAY
$239M
| $1.25M | ﹤0.01% |
+25,000
| New | +$1.23M |
2019 Q1
0 quarters
|
|
|
TWNK
3512
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $1.24M | ﹤0.01% |
99,493
-22,189
| -18% | -$259K |
2017 Q2
7 quarters
|
|
3513
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$674M
| $1.24M | ﹤0.01% |
24,573
+13,501
| +122% | +$669K |
2016 Q4
9 quarters
|
|
3514
Gibraltar Industries
ROCK
$1.21B
| $1.24M | ﹤0.01% |
30,456
+2,425
| +9% | +$92.5K |
2013 Q2
23 quarters
|
|
|
TARO
3515
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.24M | ﹤0.01% |
11,430
-7,119
| -38% | -$709K |
2015 Q4
13 quarters
|
|
|
CLLS
3516
Cellectis
CLLS
$141M
| $1.24M | ﹤0.01% |
67,301
+12,824
| +24% | +$227K |
2017 Q3
6 quarters
|
|
3517
iShares S&P India Nifty 50 Index Fund
INDY
$496M
| $1.23M | ﹤0.01% |
32,472
+1,739
| +6% | +$61.6K |
2017 Q2
7 quarters
|
|
|
WNS
3518
DELISTED
WNS Holdings
WNS
| $1.23M | ﹤0.01% |
23,134
-102,582
| -82% | -$5.14M |
2016 Q3
10 quarters
|
|
3519
PUT
Philip Morris
PM
$297B
| $1.23M | ﹤0.01% |
13,900
-30,700
| -69% | -$2.47M |
2018 Q2
3 quarters
|
|
3520
PUT
Lennar Class A
LEN
$18.4B
| $1.23M | ﹤0.01% |
25,825
-46,485
| -64% | -$2.1M |
2018 Q2
3 quarters
|
|
|
CTLT
3521
CALL
DELISTED
CATALENT, INC.
CTLT
| $1.23M | ﹤0.01% |
+30,200
| New | +$1.18M |
2019 Q1
0 quarters
|
|
|
AVB
3522
CALL
DELISTED
AvalonBay Communities
AVB
| $1.22M | ﹤0.01% |
6,100
-3,000
| -33% | -$573K |
2017 Q4
5 quarters
|
|
3523
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.43B
| $1.22M | ﹤0.01% |
24,262
+13,413
| +124% | +$670K |
2018 Q2
3 quarters
|
|
3524
Karyopharm Therapeutics
KPTI
$14.7M
| $1.22M | ﹤0.01% |
13,902
+6,070
| +78% | +$673K |
2013 Q4
21 quarters
|
|
|
CTLT
3525
PUT
DELISTED
CATALENT, INC.
CTLT
| $1.22M | ﹤0.01% |
+30,000
| New | +$1.17M |
2019 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.